R. Pivonello Et Al. , "Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study," CLINICAL ENDOCRINOLOGY , vol.81, no.3, pp.408-417, 2014
Pivonello, R. Et Al. 2014. Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study. CLINICAL ENDOCRINOLOGY , vol.81, no.3 , 408-417.
Pivonello, R., Petersenn, S., Newell-Price, J., Findling, J. W., Gu, F., Maldonado, M., ... Trovato, A.(2014). Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study. CLINICAL ENDOCRINOLOGY , vol.81, no.3, 408-417.
Pivonello, Rosario Et Al. "Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study," CLINICAL ENDOCRINOLOGY , vol.81, no.3, 408-417, 2014
Pivonello, Rosario Et Al. "Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study." CLINICAL ENDOCRINOLOGY , vol.81, no.3, pp.408-417, 2014
Pivonello, R. Et Al. (2014) . "Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study." CLINICAL ENDOCRINOLOGY , vol.81, no.3, pp.408-417.
@article{article, author={Rosario Pivonello Et Al. }, title={Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study}, journal={CLINICAL ENDOCRINOLOGY}, year=2014, pages={408-417} }